Search

Cannabis Law Partner Zachary Kobrin published an article for the Cannabis Industry Journal on how the cannabis industry can benefit from the Capital Lending and Investment for Marijuana Businesses (CLIMB) Act which was recently introduced in Congress. The Act creates greater access to capital...

Midyear Cannabis Update: 4 Industry Trends to Watch Saul Ewing’s Jonathan Havens shares the biggest developments he’s seen so far in 2022, as well as which trends industry stakeholders should watch during the second half of the year.

FDA Bans JUUL Products From US Market Cannabis industry stakeholders weigh in on what the decision could mean for businesses in the cannabis space. By Melissa Schiller On the other hand, Jonathan Havens, co-chair of Saul Ewing’s Cannabis Law Practice and chair of the firm’s Food, Beverage and...

FDA takes another look at CBD, but insiders are skeptical much will change U.S. health regulators are taking their closest look in more than three years at the idea of incorporating cannabinoids into dietary supplements. But hopes are dim that Tuesday’s daylong review by the U.S. Food and Drug...